Ischemic heart disease Board decisions

The Board has determined that the Veteran's cause of death is not related to his service, and therefore denied the claim for service connection for cause of death.

The Board denied the Veteran's claim for service connection for heart disease as there is no current diagnosis of heart disease in the record.

The Veteran's tinnitus is granted service connection and a 60 percent rating for hypertensive heart disease, status post mitral valve repair to include valvular heart disease is granted.

The Board has remanded the Veteran's claims for service connection for coronary artery disease and essential head tremor, both of which are related to exposure to contaminated water at Camp Lejeune. The VA will obtain medical opinions to determine if these conditions are related to service.

The Board has determined that the Veteran's claims for service connection and a compensable rating for his right ear hearing loss, heart condition, hypertension, and anemia are remanded due to incomplete evidence. The VA will obtain any outstanding treatment records and schedule the Veteran for VA examinations to address the nature and etiology of these conditions.

The Veteran's service-connected PSVT, arteriosclerotic heart disease, coronary artery bypass graft, myocardial infarction, and AICD are so inter-related that they cannot be separated. The Board grants an initial 100 percent rating for the combined conditions.

The Board has found that new and relevant evidence supports readjudicating the claims for diabetes, hypertension, sleep apnea, and heart disability. The AOJ must now adjudicate these claims based on this new evidence.

The Veteran's claim for service connection for coronary artery disease, angioplasty with stent placement and atrial flutter was denied. The Board found that the earliest effective date available is November 9, 2020.

The Board has determined that new and relevant evidence has been received, warranting readjudication of the claim for service connection for a heart disorder. The appeal is remanded due to the need for further examination and opinion regarding the etiology of any identified heart disorders.

The Board denied the Veteran's claims for earlier effective dates for service connection due to lack of new and material evidence within one year of final decisions, and because the Veteran did not have exposure to herbicide agents under the PACT Act.

The Veteran's TDIU claim is denied prior to March 14, 2017, and dismissed as moot for the period after that date due to his 100% disability rating for IHD.

The Veteran's hypertension and arteriosclerotic heart disease are service-connected, with the latter being secondary to the former.,The cause of death is attributed to bilateral pneumonia and congestive heart failure, which were related to the Veteran's service-connected conditions.

The Veteran's appeals for increased ratings have been dismissed due to his withdrawal of the appeal.

The Veteran's claim for a higher rating for bilateral hearing loss was denied as it did not meet the criteria for an effective date prior to November 21, 2022.,Service connection for hypothyroidism and emphysema were granted with an effective date of November 21, 2022. Service connection for arteriosclerotic heart disease was granted with a rating of 60 percent but no higher, also with an effective date of June 13, 2023.

The Board has remanded the claims of service connection for transverse myelitis, a heart disorder (claimed as heart failure takotsubo), and hypertension due to potential errors in the duty to assist.

The Veteran's service connection claims for coronary artery disease and prostate cancer are granted due to presumed exposure to herbicide agents in Guam, effective October 1, 2022.

The Veteran's surviving spouse is granted an earlier effective date of August 1, 2004, for Dependency and Indemnity Compensation (DIC) and basic eligibility to Dependents' Educational Assistance (DEA). The effective dates are based on the Agent Orange presumption.

The Veteran's service-connected coronary artery disease to include coronary artery bypass graft, patent foramen ovale closure, percutaneous coronary intervention (cardiac stent), atrial flutter and myocardial infarction is rated at 100 percent since February 6, 2020.

The Board has granted an earlier effective date of February 28, 2018, for the grant of a total disability rating based on individual unemployability (TDIU) due to service-connected conditions including coronary artery disease, PTSD, and bilateral hearing loss.

The Board has remanded the Veteran's claims for coronary artery disease with valvular and hypertensive heart disease, as well as skin cancer, due to presumed herbicide exposure in Korea. The VA is required to obtain medical opinions addressing these conditions.